WallStreetZenWallStreetZen

NASDAQ: VYGR
Voyager Therapeutics Inc Stock Ownership - Who owns Voyager Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Voyager Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Robin SwartzCOO CBO2026-02-246,458$3.77
$24.35kSell
Todd Alfred CarterChief Scientific Officer2026-02-244,174$3.76
$15.69kSell
Alfred SandrockPresident and CEO2026-02-2414,197$3.79
$53.81kSell
Nathan D. JorgensenChief Financial Officer2026-02-244,668$3.77
$17.60kSell
Todd Alfred CarterChief Scientific Officer2026-02-183,301$3.44
$11.36kSell
Robin SwartzCOO CBO2026-02-183,882$3.44
$13.35kSell
Alfred SandrockPresident and CEO2026-02-1811,732$3.41
$40.01kSell
Todd Alfred CarterChief Scientific Officer2026-02-103,525$3.85
$13.57kSell
Alfred SandrockPresident and CEO2026-02-1012,192$3.78
$46.09kSell
Robin SwartzCOO CBO2026-02-104,569$3.85
$17.59kSell

1 of 2

VYGR insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when VYGR insiders and whales buy or sell their stock.

VYGR Shareholders

What type of owners hold Voyager Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Neurocrine Biosciences Inc14.39%8,575,316$33.96MInsider
Ecor1 Capital LLC13.64%8,128,014$32.19MInsider
Mark J. Levin10.79%6,427,874$25.45MInsider
Blackrock Inc9.43%5,618,365$22.25MInstitution
Ecor1 Capital LLC6.72%4,002,847$15.85MInstitution
Armistice Capital LLC6.71%4,000,000$15.84MInstitution
Vanguard Group Inc5.48%3,266,484$12.94MInstitution
Sanofi4.16%2,477,941$9.81MInsider
Millennium Management LLC3.16%1,880,760$7.45MInstitution
Vestal Point Capital LP2.47%1,475,000$5.84MInstitution

1 of 3

VYGR vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
VYGR53.27%46.73%Net SellingNet Selling
CCCC80.10%19.90%Net SellingNet Selling
CNTX70.98%1.43%Net Buying
ANL0.05%0.00%
SLN12.77%0.09%
View Top Biotech Stocks

Voyager Therapeutics Stock Ownership FAQ

Who owns Voyager Therapeutics?

Voyager Therapeutics (NASDAQ: VYGR) is owned by 56.61% institutional shareholders, 49.66% Voyager Therapeutics insiders, and 0.00% retail investors. Neurocrine Biosciences Inc is the largest individual Voyager Therapeutics shareholder, owning 8.58M shares representing 14.39% of the company. Neurocrine Biosciences Inc's Voyager Therapeutics shares are currently valued at $33.96M.

If you're new to stock investing, here's how to buy Voyager Therapeutics stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.